# 2026-05912: DEA Eyes Bulk Production of Psilocybin and Fentanyl—Wait, What?

2026-05912, Bulk Manufacturer of Controlled Substances Application: SpecGx LLC, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-03-26, effective 2026-05-26; PRIA reads it as touching household money (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-05912
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-05912
- Title: Bulk Manufacturer of Controlled Substances Application: SpecGx LLC
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 14721
- Published: 2026-03-26
- Effective: 2026-05-26
- Comments close: 2026-05-26
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

DEA Eyes Bulk Production of Psilocybin and Fentanyl—Wait, What?

## Summary

SpecGx LLC wants to become a big-time maker of some powerful and tightly controlled drugs, including things like psilocybin and fentanyl. People and companies already registered can share their thoughts or ask for a hearing by May 26, 2026. This move could shake up how these substances are made and handled, so keep an eye on the deadlines if you’re involved!

## Abstract

SpecGx LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

## Effects PRIA read

- SpecGx Applied To Bulk-Produce Many Drugs: mixed, low. SpecGx LLC applied on February 4, 2026 to be registered as a bulk manufacturer for many Schedule I and II controlled substances, including psilocybin (code 7437), fentanyl and related compounds (codes 9801, 9821, 9822, 9850), tetrahydrocannabinols (code 7370), and gamma hydroxybutyric acid (code 20…
- Deadline to Comment or Request Hearing: mixed, low. Registered bulk manufacturers of the affected drug classes and applicants may submit electronic comments or objections, or file a written request for a hearing, on or before May 26, 2026. Comments must be submitted via https://www.regulations.gov and commenters will receive a Comment Tracking Numbe…
- Planned Sale And Internal Use Of Manufactured Drugs: mixed, low. SpecGx plans to bulk manufacture the listed controlled substances for sale to its customers and for internal use to produce non-controlled substances, according to the application text. The registration, if granted, would be limited to the activities listed for those drug codes.
- THC Manufacture Limited To Synthetic Form: mixed, low. For drug code 7370 (Tetrahydrocannabinols), SpecGx states it plans to bulk manufacture this drug code as synthetic. The application notes that no other activities for these drug codes are authorized by this registration.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2026-05912 on federalregister.gov](https://www.federalregister.gov/documents/2026/03/26/2026-05912/bulk-manufacturer-of-controlled-substances-application-specgx-llc)
- [2026-05912 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-03-26/pdf/2026-05912.pdf)

## Related
- [Previous: 2026-05911, Notice Pursuant to the National Cooperative Research and Production Act of 1993…](https://policyrisk.com/federal-register/2026-05911)
- [Next: 2026-05913, Elite Laboratories, Inc., et al.; Withdrawal of Approval of 72 Abbreviated New…](https://policyrisk.com/federal-register/2026-05913)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-05912 (as of 2026-06-08).
